Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
A B Dietz, M R Litzow, P A Bulur & S Vuk-Pavlović. (2001) Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous T H 1 T cells. Cytotherapy 3:2, pages 97-105.
Read now
Read now
Seema Singhal, Ray Powles, Samar Kulkarni, Jennifer Treleaven, Radovan Saso & Jayesh Mehta. (1999) Long-Term Follow-Up of Relapsed Acute Leukemia Treated with Immunotherapy After Allogeneic Transplantation: the Inseparability of Graft-Versus-Host Disease and Graft-Versus-Leukemia, and the Problem of Extramedullary Relapse. Leukemia & Lymphoma 32:5-6, pages 505-512.
Read now
Read now
Jayesh Mehta, Ray Powles, Jennie Treleaven, Clive Horton, Val Shepherd, Geoff Hale, Herman Waldmann & Seema Singhal. (1997) Autologous Transplantation with CD52 Monoclonal Antibody-Purged Marrow for Acute Lymphoblastic Leukemia: Long-Term Follow-Up. Leukemia & Lymphoma 25:5-6, pages 479-486.
Read now
Read now
Seema Singhal, Ray Powles, Jennie Treleaven, Clive Horton & Jayesh Mehta. (1997) Long-Term Safety of GM-CSF (Molgramostim) Administration After Allogeneic Bone Marrow Transplantation for Hematologic Malignancies: Five-Year Follow-Up of a Double-Blind Randomized Placebo-Controlled Study. Leukemia & Lymphoma 24:3-4, pages 301-307.
Read now
Read now
J. Mehta, R. Powles, S. Singhal, G. J. Swansbury, B. Millar, V. Shepherd, J. Bell, T. Min, S. Cabral & J. Treleaven. (1996) High-dose Hydroxyurea and G-CSF to Collect Philadelphia-Negative Cells in Chronic Myeloid Leukemia: Preliminary Results. Leukemia & Lymphoma 23:1-2, pages 107-111.
Read now
Read now
Articles from other publishers (19)
Brian D. Friend & Gary J. Schiller. (2022) Beyond steroids: A systematic review and proposed solutions to managing acute graft-versus-host disease in adolescents and young adults. Blood Reviews 52, pages 100886.
Crossref
Crossref
Yair Reisner & Noga Or-Geva. (2019) Veto cells for safer nonmyeloablative haploidentical HSCT and CAR T cell therapy. Seminars in Hematology 56:3, pages 173-182.
Crossref
Crossref
Judith Hammrich, Susan Wittig, Thomas Ernst & Bernd Gruhn. (2019) CTLA‐4 polymorphism rs231775: Influence on relapse and survival after allogeneic hematopoietic stem cell transplantation in childhood. European Journal of Haematology 102:3, pages 251-255.
Crossref
Crossref
Nathan Singh, Xiaojun Liu, Jessica Hulitt, Shuguang Jiang, Carl H. June, Stephan A. Grupp, David M. Barrett & Yangbing Zhao. (2014) Nature of Tumor Control by Permanently and Transiently Modified GD2 Chimeric Antigen Receptor T Cells in Xenograft Models of Neuroblastoma. Cancer Immunology Research 2:11, pages 1059-1070.
Crossref
Crossref
David M. BarrettYangbing ZhaoXiaojun LiuShuguang JiangCarmine CarpenitoMichael KalosRichard G. CarrollCarl H. JuneStephan A. Grupp. (2011) Treatment of Advanced Leukemia in Mice with mRNA Engineered T Cells. Human Gene Therapy 22:12, pages 1575-1586.
Crossref
Crossref
Arnon Nagler, Raanan Berger, Aliza Ackerstein, Jaroslaw A. Czyz, Jose Luis Diez-Martin, Elizabeth Naparstek, Reuven Or, Shlomit Gan, Avichai Shimoni & Shimon Slavin. (2010) A Randomized Controlled Multicenter Study Comparing Recombinant Interleukin 2 (rIL-2) in Conjunction With Recombinant Interferon Alpha (IFN-α) Versus no Immunotherapy for Patients With Malignant Lymphoma Postautologous Stem Cell Transplantation. Journal of Immunotherapy 33:3, pages 326-333.
Crossref
Crossref
Yaron Ilan, Maya Margalit, Meir Ohana, Israel Gotsman, Elazar Rabbani, Dean Engelhardt & Arnon Nagler. (2005) Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect. Human Immunology 66:3, pages 231-240.
Crossref
Crossref
S Singhal, P J Henslee-Downey, R Powles, K Y Chiang, K Godder, J Treleaven, S Kulkarni, F van Rhee, B Sirohi, C R Pinkerton, S Meller, B Jovanovic & J Mehta. (2003) Haploidentical vs autologous hematopoietic stem cell transplantation in patients with acute leukemia beyond first remission. Bone Marrow Transplantation 31:10, pages 889-895.
Crossref
Crossref
S Singhal, R Powles, PJ Henslee-Downey, KY Chiang, J Treleaven, K Godder, S Kulkarni, F van Rhee, B Sirohi, CR Pinkerton, S Meller & J Mehta. (2002) Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia. Bone Marrow Transplantation 29:4, pages 291-295.
Crossref
Crossref
Ray Powles, Jayesh Mehta, Samar Kulkarni, Jennifer Treleaven, Barbara Millar, Jill Marsden, Val Shepherd, April Rowland, Bhawna Sirohi, Diana Tait, Clive Horton, Simon Long & Seema Singhal. (2000) Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial. The Lancet 355:9211, pages 1231-1237.
Crossref
Crossref
John BarrettJayesh Mehta. 2000. Allogeneic Immunotherapy for Malignant Diseases. Allogeneic Immunotherapy for Malignant Diseases.
Naoto T. Ueno, Gabriel N. Hortobagyi & Richard E. Champlin. 1999. Advances in Allogeneic Hematopoietic Stem Cell Transplantation. Advances in Allogeneic Hematopoietic Stem Cell Transplantation
133
156
.
Ray PowlesSeema SinghalJennifer TreleavenSamar KulkarniClive HortonJayesh Mehta. (1998) Identification of Patients Who May Benefit From Prophylactic Immunotherapy After Bone Marrow Transplantation for Acute Myeloid Leukemia on the Basis of Lymphocyte Recovery Early After Transplantation. Blood 91:9, pages 3481-3486.
Crossref
Crossref
A. NaglerA. AckersteinR. OrE. NaparstekS. Slavin. (1997) Immunotherapy With Recombinant Human Interleukin-2 and Recombinant Interferon-α in Lymphoma Patients Postautologous Marrow or Stem Cell Transplantation. Blood 89:11, pages 3951-3959.
Crossref
Crossref
Seema Singhal, Urania Vourka-Karussis, Jayesh Mehta, Shimon Slavin & Lola Weiss. (1996) Failure of cyclosporine to induce graft-vs-host disease or graft-vs-leukemia after syngeneic bone marrow transplantation in mice. Leukemia Research 20:11-12, pages 941-946.
Crossref
Crossref
Arnon Nagler, Irena Shur, Vivian Barak & Ina Fabian. (1996) Granulocyte-macrophage colony-stimulating factor dependent monocyte-mediated cytotoxicity post-autologous bone marrow transplantation. Leukemia Research 20:8, pages 637-643.
Crossref
Crossref
Reba Condiotti, Shimon Slavin & Arnon Nagler. (1996) ASTA-Z 7557 impairs human natural killer (NK) cell activity. Leukemia Research 20:2, pages 169-174.
Crossref
Crossref
Reba Condiotti, Shimon Slavin, Vivian Barak & Arnon Nagler. (1996) The novel immunomodulator, Linomide, stimulates interleukin-2-induced human natural killer (NK) cell and PHA-stimulated T cell proliferation from normal donors. Leukemia Research 20:1, pages 57-63.
Crossref
Crossref
Amos Toren, Aliza Ackerstein, Shimon Slavin & Arnon Nagler. (1995) Role of interleukin-2 in human hematological malignancies. Medical Oncology 12:3, pages 177-186.
Crossref
Crossref